文献速递心脑血管急症重症综合管理与镇静镇痛

早期微创清除脑出血的随机试验

Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage.
PubMed 文献 · N Engl J Med · 2024-01-01
一句话结论急性脑出血24小时内行微创血肿清除,180天功能结局优于单纯内科管理,获益主要见于脑叶出血。

这项多中心随机试验纳入300例急性幕上脑出血(血肿量30–80 ml)患者,1:1分配至微创手术+指南内科管理组或单纯指南内科管理组,主要终点为180天效用加权改良Rankin量表评分。手术组平均评分0.458 vs 对照组0.374(差值0.084,95%贝叶斯可信区间0.005–0.163,手术优效后验概率0.981)。脑叶出血亚组组间平均差值0.127(95%贝叶斯可信区间0.035–0.219),前部基底节出血亚组为-0.013(95%贝叶斯可信区间-0.147–0.116)。30天死亡率手术组9.3% vs 对照组18.0%。

要点

  • 急性脑出血24小时内微创血肿清除+指南内科管理较单纯内科管理改善180天效用加权改良Rankin评分(0.458 vs 0.374,差值0.084,95%贝叶斯可信区间0.005–0.163)。
  • 获益主要见于脑叶出血:组间平均差值0.127(95%贝叶斯可信区间0.035–0.219);前部基底节出血为-0.013(95%贝叶斯可信区间-0.147–0.116)。
  • 30天死亡率手术组9.3% vs 对照组18.0%。
  • 手术组5例(3.3%)出现术后再出血并神经功能恶化。
  • 入组175例后触发适应性规则,此后仅纳入脑叶出血患者。

适用人群与场景

  • 急性脑叶或前部基底节出血、血肿量30–80 ml、在最后确认正常后24小时内可手术的患者;入组175例后仅纳入脑叶出血患者。

诊断标准与关键阈值

  • 血肿量30–80 ml;幕上脑叶或前部基底节出血;最后确认正常后24小时内。

处置流程与药物剂量

  • 微创手术清除血肿+指南为基础的内科管理(手术组) vs 单纯指南为基础的内科管理(对照组),1:1随机分配。

研究设计与关键结果

  • 多中心随机试验纳入300例,30.7%前部基底节出血、69.3%脑叶出血;180天效用加权改良Rankin评分手术组0.458 vs 对照组0.374(差值0.084,95%贝叶斯可信区间0.005–0.163,手术优效后验概率0.981)。
  • 脑叶出血亚组组间平均差值0.127(95%贝叶斯可信区间0.035–0.219);前部基底节出血亚组-0.013(95%贝叶斯可信区间-0.147–0.116)。
  • 30天死亡率手术组9.3% vs 对照组18.0%;手术组5例(3.3%)术后再出血并神经功能恶化。

证据类型、等级与局限

  • 多中心随机试验;预设优效后验概率阈值0.975,实际后验概率0.981;作者认为手术效果似乎归因于脑叶出血的干预。

对床旁实践的改变

  • 对急性脑叶出血(血肿量30–80 ml)且在最后确认正常后24小时内可手术者,微创血肿清除+指南内科管理较单纯内科管理改善180天功能结局。
  • 前部基底节出血患者中未观察到手术获益(组间平均差值-0.013,95%贝叶斯可信区间-0.147–0.116)。
  • 手术组术后再出血并神经功能恶化的发生率为3.3%(5例)。

指南或共识出处

  • ENRICH ClinicalTrials.gov number, NCT02880878;由Nico资助。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Trials of surgical evacuation of supratentorial intracerebral hemorrhages have generally shown no functional benefit. Whether early minimally invasive surgical removal would result in better outcomes than medical management is not known.

METHODS: In this multicenter, randomized trial involving patients with an acute intracerebral hemorrhage, we assessed surgical removal of the hematoma as compared with medical management. Patients who had a lobar or anterior basal ganglia hemorrhage with a hematoma volume of 30 to 80 ml were assigned, in a 1:1 ratio, within 24 hours after the time that they were last known to be well, to minimally invasive surgical removal of the hematoma plus guideline-based medical management (surgery group) or to guideline-based medical management alone (control group). The primary efficacy end point was the mean score on the utility-weighted modified Rankin scale (range, 0 to 1, with higher scores indicating better outcomes, according to patients' assessment) at 180 days, with a prespecified threshold for posterior probability of superiority of 0.975 or higher. The trial included rules for adaptation of enrollment criteria on the basis of hemorrhage location. A primary safety end point was death within 30 days after enrollment.

RESULTS: A total of 300 patients were enrolled, of whom 30.7% had anterior basal ganglia hemorrhages and 69.3% had lobar hemorrhages. After 175 patients had been enrolled, an adaptation rule was triggered, and only persons with lobar hemorrhages were enrolled. The mean score on the utility-weighted modified Rankin scale at 180 days was 0.458 in the surgery group and 0.374 in the control group (difference, 0.084; 95% Bayesian credible interval, 0.005 to 0.163; posterior probability of superiority of surgery, 0.981). The mean between-group difference was 0.127 (95% Bayesian credible interval, 0.035 to 0.219) among patients with lobar hemorrhages and -0.013 (95% Bayesian credible interval, -0.147 to 0.116) among those with anterior basal ganglia hemorrhages. The percentage of patients who had died by 30 days was 9.3% in the surgery group and 18.0% in the control group. Five patients (3.3%) in the surgery group had postoperative rebleeding and neurologic deterioration.

CONCLUSIONS: Among patients in whom surgery could be performed within 24 hours after an acute intracerebral hemorrhage, minimally invasive hematoma evacuation resulted in better functional outcomes at 180 days than those with guideline-based medical management. The effect of surgery appeared to be attributable to intervention for lobar hemorrhages. (Funded by Nico; ENRICH ClinicalTrials.gov number, NCT02880878.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Pradilla G, Ratcliff JJ, Hall AJ, et al. Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage. N Engl J Med. 2024. PMID: 38598795. doi:10.1056/NEJMoa2308440

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。